• SKIP TO CONTENT
  • SKIP NAVIGATION
  • Patient Resources
    • Clinical Trial Listings
    • What is Clinical Research?
    • Volunteering for a Clinical Trial
    • Understanding Informed Consent
    • Useful Resources
    • FDA Approved Drugs
  • Professional Resources
    • Research Center Profiles
    • Market Research
    • Benchmark Reports
    • FDA Approved Drugs
    • Training Guides
    • Books
    • eLearning
    • Events
    • Newsletters
    • White Papers
    • SOPs
  • White Papers
  • Clinical Trial Listings
  • Advertise
  • Sign In
  • Create Account
  • Sign Out
  • My Account
Home » German CRO Clinicalprojects Plans to Open First Foreign Office

German CRO Clinicalprojects Plans to Open First Foreign Office

February 19, 2010
CenterWatch Staff

German contract research organization (CRO) Clinicalprojects is preparing to expand its services and global footprint in 2010, but founder Joerg Breitkopf said the company’s growth will be controlled.

Clinicalprojects does work in 10 European countries—the UK, France, the Netherlands, Poland, Austria, Switzerland, Italy, Spain, Portugal and Czech Republic—but only has an office in Germany. The CRO plans to open the company’s first foreign office in Italy in the first half of year. Breitkopf is still negotiating where the office will be located but said it will be near Milan.

Clinicalprojects wants to be an international CRO with very local roots, Breitkopf said. When he founded the company in 2007, he opened its headquarters in Germany because that’s where he and his family lived. Similarly, Breitkopf has worked in Italy and would consider living there if he ever left Germany.

“I’ve worked in the clinical trials field already for some years. Whenever I worked with Italy and the Italian people and saw their high dedication to the quality of work, that was something I always kept in mind,” he said.

Clinicalprojects has three people already working in Italy. The company plans to hire a business development person to staff the new office.

Although Breitkopf said Italy is well-suited to clinicalprojects’ first international office, he warned that the country may not be a good starting point for most companies.

“Italy is a very difficult market for clinical trials because the legislation there is a little bit tricky. To run clinical trials, you really need to have good people on the ground. Otherwise, it would be my recommendation not to go to Italy because it’s so complex. We are used to tricky, and we like the challenges,” he said.

Clinicalprojects may also open offices in the UK and Spain this year, depending on how the Italy office goes. The CRO already has three people working in the UK, and 20 full-time employees overall.

 

 

    Upcoming Events

    • 16Oct

      MAGI@home Clinical Research Conference 2023

    • 25Oct

      2023 WCG Patient Forum

    • 26Oct

      FDA in 2024: What to Expect in an Election Year

    Featured Products

    • Surviving an FDA GCP Inspection

      Surviving an FDA GCP Inspection: Resources for Investigators, Sponsors, CROs and IRBs

    • Best Practices for Clinical Trial Site Management

      Best Practices for Clinical Trial Site Management

    Featured Stories

    • Donna Snyder

      New WCG Executive Physician Outlines Goals for Clinical Research

    • Hand Shake at Meeting

      Partnership to Bolster Trials in Low Resource Regions Kicks Off

    • Guidelines-360x240.png

      Major Industry Groups Offer Feedback on ICH’s E6(R3) Guidelines

    • AsktheExpertsBadge-360x240.png

      Ask the Experts: Monitoring

    Standard Operating Procedures for Risk-Based Monitoring of Clinical Trials

    The information you need to adapt your monitoring plan to changing times.

    Learn More Here
    • About Us
    • Contact Us
    • Privacy Policy
    • Do Not Sell or Share My Data

    Footer Logo

    300 N. Washington St., Suite 200, Falls Church, VA 22046, USA

    Phone 703.538.7600 – Toll free 888.838.5578

    Copyright © 2023. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing